Singapore markets closed

Pyxis Oncology, Inc. (PYXS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.3800-0.0300 (-0.68%)
At close: 04:00PM EDT
4.4000 +0.02 (+0.46%)
After hours: 04:52PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
49,586
49,586
86,129
51,054
9,048
Selling general and administrative
32,610
32,610
37,352
18,663
3,846
Total operating expenses
82,196
82,196
123,481
69,717
12,894
Operating income or loss
-82,196
-82,196
-123,481
-69,717
-12,894
Total other income/expenses net
1,776
1,776
-
-6,281
-
Income before tax
-73,790
-73,790
-120,717
-75,975
-12,828
Income from continuing operations
-73,790
-73,790
-120,717
-75,975
-12,828
Net income
-73,790
-73,790
-120,717
-75,975
-12,828
Net income available to common shareholders
-73,790
-73,790
-120,717
-75,975
-12,828
Basic EPS
-2.56
-
-3.65
-8.95
-0.58
Diluted EPS
-2.56
-
-3.65
-8.95
-0.58
Basic average shares
37,485
-
33,033
8,493
22,127
Diluted average shares
37,485
-
33,033
8,493
22,127